HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 33/3/612    most recent 09031936.00014808v1 Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Fu, P. Articles by Birukov, K. G. Search for Related Content PubMed PubMed Citation Articles by Fu, P. Articles by Birukov, K. G.

Amifostine reduces lung vascular permeability via suppression of inflammatory signalling

¹ Section of Pulmonary and Critical Care Medicine, Dept of Medicine, and ² Dept of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA.

CORRESPONDENCE: K. G. Birukov, Section of Pulmonary and Critical Care Medicine, Dept of Medicine, University of Chicago, 929 E. 57th Street, GCIS Bldg, Room W410, Chicago, IL 60637, USA. Fax: 1 7738342683. E-mail: kbirukov{at}medicine.bsd.uchicago.edu

Keywords: Endothelium, lipopolysaccharide, lung, permeability, reactive oxygen species

Received: January 30, 2008
Accepted October 8, 2008

Despite an encouraging outcome of antioxidant therapy in animal models of acute lung injury, effective antioxidant agents for clinical application remain to be developed. The present study investigated the effect of pre-treatment with amifostine, a thiol antioxidant compound, on lung endothelial barrier dysfunction induced by Gram-negative bacteria wall-lipopolysaccharide (LPS).

Endothelial permeability was monitored by changes in transendothelial electrical resistance. Cytoskeletal remodelling and reactive oxygen species (ROS) production was examined by immunofluorescence. Cell signalling was assessed by Western blot. Measurements of Evans blue extravasation, cell count and protein content in bronchoalveolar lavage fluid were used as in vivo parameters of lung vascular permeability.

Hydrogen peroxide, LPS and interleukin-6 caused cytoskeletal reorganisation and increased permeability in the pulmonary endothelial cells, reflecting endothelial barrier dysfunction. These disruptive effects were inhibited by pre-treatment with amifostine and linked to the amifostine-mediated abrogation of ROS production and redox-sensitive signalling cascades, including p38, extracellular signal regulated kinase 1/2, mitogen-activated protein kinases and the nuclear factor-B pathway. In vivo, concurrent amifostine administration inhibited LPS-induced oxidative stress and p38 mitogen-activated protein kinase activation, which was associated with reduced vascular leak and neutrophil recruitment to the lungs.

The present study demonstrates, for the first time, protective effects of amifostine against lipopolysaccharide-induced lung vascular leak in vitro and in animal models of lipopolysaccharide-induced acute lung injury.